Introduction
Chronic mesenteric ischemia (CMI) represents a serious vascular condition characterized by insufficient blood supply to the digestive organs, failing to meet their metabolic needs. Primarily arising from atherosclerotic narrowing of the mesenteric vessels, particularly the superior mesenteric artery (SMA), CMI shares common risk factors with other atherosclerotic diseases such as coronary artery disease and peripheral vascular disease, including smoking, hyperlipidemia, diabetes, and hypertension. Patients often experience postprandial abdominal pain, known as “abdominal angina,” typically occurring 15 to 30 minutes after meals and lasting up to four hours. This pain, along with nonspecific symptoms like nausea, vomiting, early satiety, diarrhea, or constipation, can make Chronic Mesenteric Ischemia Diagnosis challenging. The fear of pain after eating often leads to significant weight loss, further complicating the clinical picture.
Accurate chronic mesenteric ischemia diagnosis is critical due to its potential for severe complications and high mortality if left untreated. While clinical suspicion is important, definitive diagnosis relies on vascular imaging techniques. CT angiography (CTA) is frequently the initial diagnostic modality, while duplex ultrasonography and digital subtraction angiography (DSA) also play crucial roles, with DSA considered the gold standard in uncertain cases. Management strategies range from conservative approaches for asymptomatic patients, involving lifestyle changes and antiplatelet therapy, to surgical revascularization for symptomatic individuals. Given that untreated symptomatic CMI has a mortality rate approaching 100% within 5 years, prompt and accurate chronic mesenteric ischemia diagnosis and subsequent intervention are paramount. This article aims to enhance healthcare professionals’ understanding of CMI, focusing on its pathophysiology, chronic mesenteric ischemia diagnosis process, and optimal interprofessional management to improve patient outcomes.
Etiology of Chronic Mesenteric Ischemia
Atherosclerosis stands as the primary cause of chronic mesenteric ischemia. This condition leads to the progressive narrowing of mesenteric vessels, significantly reducing blood flow to the gastrointestinal tract. The narrowing often occurs at the origin points of these vessels, particularly the SMA, disrupting the critical balance between oxygen supply and demand in the intestine. During digestion, when blood flow requirements increase, these compromised vessels are unable to meet the heightened demand. This results in severe abdominal pain and can progress to mesenteric ischemia if untreated. Therefore, understanding the etiology is crucial for effective chronic mesenteric ischemia diagnosis.
Predisposing factors for atherosclerosis in mesenteric vessels are consistent with general atherosclerotic risk factors: diabetes, hypertension, smoking, and hyperlipidemia. Smoking and hyperlipidemia are particularly strongly associated with the development of SMA atherosclerosis. Recognizing and managing these risk factors is essential in preventing the progression of vascular compromise and mitigating the associated symptoms, which is integral to both preventing and understanding chronic mesenteric ischemia diagnosis.
Epidemiology of Chronic Mesenteric Ischemia
Mesenteric artery stenosis is a relatively common finding, affecting up to 10% of individuals over the age of 65. However, chronic mesenteric ischemia itself is a less frequent condition. Its incidence is low, accounting for fewer than 1 in 1000 hospital admissions related to abdominal pain. Typically, patients diagnosed with CMI are between 50 and 70 years old, with a notable female predominance, estimated at a 3:1 female-to-male ratio. These patients often present with other manifestations of atherosclerotic disease concurrently. Due to its relative rarity, large-scale epidemiological studies specifically focused on identifying the most at-risk populations for CMI are limited. This epidemiological context is important to consider in the differential chronic mesenteric ischemia diagnosis.
Pathophysiology of Chronic Mesenteric Ischemia
Under normal fasting conditions, approximately 20% of cardiac output is directed to the mesenteric arteries. This proportion significantly increases to about 35% after eating. Following a meal, blood flow to the gastrointestinal tract can surge by 100% to 150% above baseline, reaching around 2000 mL/min and remaining elevated for 3 to 6 hours. The mesenteric circulation is supplied by three main vessels: the celiac artery, the superior mesenteric artery (SMA), and the inferior mesenteric artery. Blood flow through these arteries increases within an hour after eating due to the increased metabolic demands of the intestinal mucosa. Diffuse atherosclerosis, typically occurring at the origins of these vessels and causing narrowing, is the primary mechanism behind CMI, accounting for 95% of cases. The understanding of this pathophysiology is fundamental for accurate chronic mesenteric ischemia diagnosis.
Angiogram illustrating superior mesenteric artery stenosis, a critical vascular abnormality in chronic mesenteric ischemia.
Patients with chronic mesenteric ischemia develop symptoms when the primary and collateral blood flow becomes insufficient to meet the increased oxygen demand during the postprandial hyperemic response. This response is essential for digestion, absorption, and peristalsis. Chronic occlusion of a single mesenteric vessel often allows for compensatory collateral blood flow, meaning symptoms typically do not manifest until at least two of the primary mesenteric vessels are significantly occluded. Shortly after eating, patients with CMI are unable to adequately increase blood flow in the mesenteric vessels, leading to the characteristic postprandial pain. Less common causes of CMI include vasculitis, fibromuscular dysplasia, and radiation-induced vascular damage. These less common etiologies should also be considered in the comprehensive chronic mesenteric ischemia diagnosis process.
Histopathology of Chronic Mesenteric Ischemia
Histopathological examination of surgically excised bowel tissue from patients with chronic mesenteric ischemia typically reveals diffuse atherosclerosis within the mesenteric vessels. A hallmark finding is the atrophy of intestinal villi. This villous atrophy reduces the absorptive surface area of the intestine, contributing to malabsorption and related symptoms often seen in CMI. These histopathological findings support the chronic mesenteric ischemia diagnosis, especially in cases requiring surgical intervention.
History and Physical Examination in Chronic Mesenteric Ischemia Diagnosis
The clinical presentation of chronic mesenteric ischemia can be varied and sometimes nonspecific, which can complicate chronic mesenteric ischemia diagnosis. Symptoms such as vague abdominal pain, nausea, vomiting, or altered bowel habits, including diarrhea or constipation, may occur without the classic postprandial pain. However, when these symptoms are accompanied by unexplained weight loss, they should raise suspicion for CMI. Endoscopic findings, if performed, may reveal diffuse small ulcerations in the stomach or proximal duodenum, or patchy ischemic areas in the colon. Abnormal liver function tests can also be present in some patients. Recognizing these subtle signs is important in prompting further investigation for chronic mesenteric ischemia diagnosis.
Clinical History for Chronic Mesenteric Ischemia Diagnosis
CMI is classically characterized by acute episodes of postprandial abdominal pain, often referred to as “abdominal angina” or “intestinal angina.” This pain typically begins 15 to 30 minutes after eating and can last up to 4 hours. The severity of the pain is often disproportionate to physical examination findings. While the pain may eventually subside, it frequently leads to a significant fear of eating, resulting in marked weight loss. Long-standing narrowing of the mesenteric vessels often manifests as nonspecific gastrointestinal symptoms like nausea, vomiting, early satiety, diarrhea, or constipation, evolving over time and becoming characteristic of CMI. Many patients have a pre-existing history of diffuse atherosclerotic disease, including angina, transient ischemic attacks, cerebrovascular accidents, or lower extremity claudication. A detailed clinical history is crucial in guiding the chronic mesenteric ischemia diagnosis process.
Physical Examination Findings in Chronic Mesenteric Ischemia Diagnosis
Physical examination findings in patients with chronic mesenteric ischemia are frequently minimal. The abdomen is typically soft and without signs of peritonitis, although mild diffuse tenderness may be present. An abdominal bruit, indicative of turbulent blood flow through narrowed vessels, may be audible in up to 50% of patients. However, the presence or absence of an abdominal bruit is neither highly sensitive nor specific for CMI. Marked weight loss is a common finding. Signs of peripheral vascular disease, such as diminished leg pulses, may also be noted. Digital rectal examination is usually guaiac negative, helping to rule out gastrointestinal bleeding as a primary cause of symptoms. A thorough history, particularly focusing on risk factors like smoking, hyperlipidemia, and claudication, is critically important in the clinical assessment and suspicion for chronic mesenteric ischemia diagnosis.
Evaluation and Diagnostic Modalities for Chronic Mesenteric Ischemia Diagnosis
The chronic mesenteric ischemia diagnosis process is often delayed because initial symptoms can mimic more common conditions causing postprandial abdominal pain and weight loss, such as peptic ulcers, cholecystitis, or malignancy. Definitive diagnosis requires vascular imaging to visualize and confirm stenosis or occlusion of the primary mesenteric vessels.
CT Angiography showcasing mesenteric artery stenosis, a key diagnostic imaging technique for chronic mesenteric ischemia.
CT angiography (CTA) is the preferred initial noninvasive imaging modality. CTA not only effectively identifies or excludes atherosclerotic stenosis of mesenteric vessels but also helps rule out other abdominal pathologies that could be causing similar symptoms. In outpatient settings, duplex ultrasonography is a reasonable screening tool. Specific hemodynamic parameters, such as peak systolic velocities exceeding 275 cm/second in the superior mesenteric artery and 200 cm/second in the celiac artery, are indicative of greater than 70% stenosis.
For cases where noninvasive imaging results are inconclusive or require further clarification, arterial digital subtraction angiography (DSA) remains the gold standard. DSA provides definitive diagnostic information and can also be used to guide therapeutic planning, especially for endovascular interventions.
Laboratory tests are not specifically diagnostic for CMI but are essential for excluding other conditions, particularly malignancies of the stomach and colon, which can present with similar symptoms. While ultrasound has limitations in sensitivity for diagnosing mesenteric ischemia, CTA has largely replaced mesenteric angiography as the primary diagnostic test due to its comparable sensitivity and its noninvasive nature. Given the frequent co-occurrence of atherosclerotic disease in CMI patients, a comprehensive evaluation for underlying cardiac and peripheral vascular disease is also essential. For patients who are heavy smokers or are being considered for surgery, arterial blood gas analysis and pulmonary function tests are recommended to optimize preoperative care and assess overall surgical risk. Therefore, a multimodal approach involving clinical assessment and advanced imaging is crucial for accurate chronic mesenteric ischemia diagnosis.
Treatment and Management Strategies for Chronic Mesenteric Ischemia
The primary objectives in treating chronic mesenteric ischemia are to alleviate abdominal symptoms, promote weight gain, and, critically, prevent progression to acute mesenteric ischemia (AMI). The timing and method of intervention are guided by the severity of the patient’s symptoms and their overall surgical risk profile. In select cases, short-term medical management, including bowel rest and parenteral nutrition, can serve as a bridge to revascularization. However, long-term reliance on parenteral nutrition or non-interventional therapy is generally discouraged, as delays in definitive revascularization have been associated with worsened clinical outcomes, including bowel infarction and sepsis related to catheter complications.
Conservative Management of Chronic Mesenteric Ischemia
The management of CMI is tailored based on the severity of symptoms and the patient’s overall condition. Asymptomatic patients are typically managed conservatively. This approach includes lifestyle modifications, such as smoking cessation, and the initiation of antiplatelet therapy to reduce cardiovascular risk. Despite these conservative measures, the 5-year mortality rate for asymptomatic patients remains significant, around 40%, with most deaths attributed to myocardial infarction or other cardiovascular causes. This highlights the systemic nature of the underlying atherosclerotic disease and the importance of comprehensive cardiovascular risk management, even in the absence of severe CMI symptoms initially detected during chronic mesenteric ischemia diagnosis.
Surgical Management of Chronic Mesenteric Ischemia
Symptomatic chronic mesenteric ischemia requires prompt intervention. Untreated symptomatic CMI has a very poor prognosis, with a 5-year mortality rate approaching 100%. Surgical or endovascular revascularization is indicated for symptomatic patients. Endovascular techniques are now often preferred due to their minimally invasive nature and lower incidence of perioperative complications compared to open surgery.
Indications for surgical intervention include:
- Signs of peritonitis on physical examination
- Massive lower gastrointestinal hemorrhage
- Persistent abdominal pain, fever, or sepsis
- Symptoms that have persisted for more than 14 to 21 days
- Chronic malabsorption leading to protein-losing colopathy
- Colonoscopic evidence of segmental colitis with frank ulceration
- Ischemic stricture and associated abdominal symptoms
Endovascular revascularization typically involves accessing the occluded mesenteric vessels via the femoral artery, followed by balloon angioplasty and stent placement to restore adequate blood flow. For patients requiring open surgical revascularization, options include antegrade inflow (e.g., aortomesenteric or aortoceliac bypass) or retrograde inflow (e.g., iliac artery bypass). These procedures often utilize either a vein or prosthetic conduit for bypass grafting. Preoperative nutritional optimization, often through total parenteral nutrition, is critically important, as many patients are malnourished at the time of chronic mesenteric ischemia diagnosis. Total parenteral nutrition may be required both before and after surgery to support nutritional status and promote healing. The choice of revascularization approach is heavily dependent on the patient’s specific anatomy and preoperative clinical status.
When endovascular techniques are not feasible, surgical options include transverse or longitudinal arteriotomy and bypass procedures. There is ongoing debate regarding the optimal conduit for bypass. While prosthetic grafts have been used, some experts advocate for the reversed saphenous vein as a preferred conduit. For surgeons less experienced with superior mesenteric bypass, it’s important to note the typical location and surgical approach to this vessel.
Postoperative Management of Chronic Mesenteric Ischemia
Postoperatively, patients require close cardiac monitoring in an intensive care unit setting due to the high risk of cardiac events. Some surgeons use intraoperative tabletop Doppler ultrasound to verify the patency of the revascularization repair. Long-term postoperative management includes critical lifestyle modifications such as smoking cessation and management of hyperlipidemia. Referrals to cardiologists and vascular surgeons are vital for ongoing comprehensive care. While the benefit of preoperative total parenteral nutrition is still debated, it may be particularly beneficial for select malnourished patients. Following successful surgery, dietary restrictions are generally unnecessary, and patients can gradually resume normal eating patterns. Comprehensive postoperative care, focusing on lifestyle changes and diligent monitoring, is essential for improving long-term outcomes in patients after chronic mesenteric ischemia diagnosis and treatment.
Surgical Complications of Chronic Mesenteric Ischemia Treatment
Surgical complications are not uncommon in the treatment of CMI due to the diffuse atherosclerosis that underlies the condition. Patients are at increased risk for myocardial infarction during and after surgery. Therefore, comprehensive preoperative assessment and meticulous perioperative hydration are crucial. Renal failure is another potential complication, highlighting the need for preoperative nephrology consultation and vigilant perioperative fluid management. Endovascular procedures carry specific risks, including groin hematoma, acute limb ischemia, mesenteric artery dissection, rupture, or embolization of atherosclerotic plaques. Awareness and proactive management of these potential complications are integral to improving patient safety and outcomes following chronic mesenteric ischemia diagnosis and surgical treatment.
Differential Diagnosis in Chronic Mesenteric Ischemia
In evaluating a patient for chronic mesenteric ischemia diagnosis, it is essential to consider a range of differential diagnoses that can present with similar abdominal symptoms. These include:
- Acute Cholecystitis
- Acute Gastritis
- Acute mesenteric ischemia (differentiating acute from chronic is crucial)
- Biliary obstruction
- Cholangitis
- Cholecystitis (chronic)
- Chronic gastritis
- Chronic pancreatitis
- Diverticulitis
- Gastric cancer
- Peptic ulcer disease
A thorough clinical evaluation and appropriate diagnostic testing are necessary to differentiate CMI from these other conditions and ensure accurate chronic mesenteric ischemia diagnosis.
Prognosis of Chronic Mesenteric Ischemia
The prognosis for chronic mesenteric ischemia is significantly influenced by the timeliness of chronic mesenteric ischemia diagnosis, the effectiveness of the treatment implemented, and the presence of any complications. Surgical management remains the standard treatment and offers long-term symptom relief for a majority of patients. Following surgical revascularization, 86% to 96% of patients remain asymptomatic over 5 to 10 years, with comparable graft patency rates. Endovascular treatment provides symptom relief in approximately 85% of patients and is considered a safe and effective alternative, although it is associated with a higher risk of restenosis and potentially shorter long-term patency compared to open surgery. Despite advancements in treatment, the mortality rate for untreated or delayed CMI remains alarmingly high, ranging from 60% to 95%.
Complications following intervention, such as access site hematomas, pseudoaneurysms, thrombosis, and bowel infarction (reported in around 4.6% of cases), can occur and may necessitate additional procedures. Reocclusion rates tend to be higher in males compared to females, and some patients may experience recurrent symptoms, leading to repeated hospital admissions. The persistent postprandial pain associated with CMI often results in significant weight loss, malnutrition, and a diminished quality of life. Chronic malnutrition can further lead to metabolic imbalances, bone thinning, easy bruising, and endocrine disturbances, exacerbating the overall burden of the disease. Early chronic mesenteric ischemia diagnosis and comprehensive management are therefore critical to improving patient outcomes and minimizing the adverse effects of this serious condition.
Complications of Chronic Mesenteric Ischemia
Complications associated with chronic mesenteric ischemia are significant and can be broadly categorized:
- Cardiovascular Complications:
- High mortality risk from adverse cardiac events, such as myocardial infarction.
- Risk of cardiac complications is exacerbated by comorbid conditions, including smoking, diabetes, hypertension, and hyperlipidemia.
- Gastrointestinal Complications:
- Bowel ischemia due to insufficient mesenteric blood supply.
- Graft thrombosis or restenosis following revascularization procedures, potentially leading to recurrent symptoms or ischemia.
- Severe cases can progress to bowel infarction, requiring emergent surgical intervention.
- Massive bowel resection, potentially leading to short gut syndrome in cases of treatment failure.
- Postsurgical or Endovascular Procedure Complications:
- Access site hematoma, pseudoaneurysm, or thrombosis.
- Long-term patency issues with endovascular revascularization, resulting in symptom recurrence.
- Complications from Delayed Diagnosis:
- High morbidity and mortality rates associated with delayed recognition and treatment of CMI.
- Progression to acute mesenteric ischemia if left untreated.
- Systemic Complications:
- Malnutrition and weight loss due to fear of eating and reduced caloric intake.
- Protein-losing colopathy secondary to chronic malabsorption.
- Risk of septic complications if bowel infarction occurs.
- Mortality:
- Overall mortality rates for untreated symptomatic CMI range from 60% to 95%.
- Morbidity rate is approximately 30%, even with treatment.
These potential complications underscore the importance of timely and accurate chronic mesenteric ischemia diagnosis and effective management.
Deterrence and Patient Education for Chronic Mesenteric Ischemia
Deterrence of CMI focuses on addressing modifiable risk factors to slow disease progression and improve patient outcomes. Smoking cessation is of paramount importance, as smoking significantly contributes to vascular damage and increases the risk of restenosis after treatment. Clinicians should educate patients on adopting heart-healthy lifestyle habits, including maintaining a balanced diet, engaging in regular physical activity, and achieving a healthy weight. These measures not only improve mesenteric circulation but also reduce the overall risk of comorbid cardiovascular conditions, which are a major cause of mortality in CMI patients. Effective management of diabetes, hypertension, and hyperlipidemia with appropriate medications and lifestyle adjustments is critical in minimizing vascular damage and preventing complications.
Patient education is vital for enhancing treatment compliance and improving quality of life. Patients should be thoroughly informed about the symptoms of CMI, including postprandial abdominal pain, and potential complications like bowel ischemia. Dietary recommendations, such as consuming smaller, more frequent meals, can help reduce the demand for mesenteric blood flow and alleviate symptoms. Post-treatment, patients need to understand the importance of follow-up care, including routine duplex ultrasonography to monitor for restenosis. Encouraging open communication between patients and clinicians fosters better adherence to treatment plans and enables early identification of recurrent symptoms. Comprehensive education and proactive management empower patients to participate actively in their care, reducing morbidity and enhancing long-term outcomes following chronic mesenteric ischemia diagnosis and treatment.
Pearls and Other Key Considerations in Chronic Mesenteric Ischemia Management
When managing CMI, it is essential to carefully weigh the benefits and limitations of different treatment options. Endovascular revascularization offers advantages such as shorter hospital stays and fewer immediate complications but has been shown to have lower long-term patency rates and a higher risk of symptom recurrence compared to open surgical revascularization. Restenosis is a significant concern, occurring in up to 40% of patients undergoing endovascular treatment, often necessitating reintervention. Regular follow-up with duplex ultrasonography to monitor blood flow velocities is therefore crucial for early detection of restenosis.
The differential diagnosis for postprandial pain is broad and includes biliary disease, peptic ulcers, pancreatitis, diverticulitis, gastric reflux, irritable bowel syndrome, and gastroparesis. Malignancy must also be considered, especially in older patients presenting with gastrointestinal symptoms and unexplained weight loss. Common procedural complications include hematomas, pseudoaneurysms, and thrombosis, with bowel infarction being a severe potential consequence. Smoking cessation remains a vital component of improving outcomes.
Post-discharge dietary advice for patients should include consuming small, frequent meals to reduce mesenteric blood flow demand. In cases where surgical intervention fails, symptoms may recur rapidly, and severe cases can unfortunately lead to massive bowel resection and short gut syndrome. Despite a notable morbidity rate of around 30%, long-term outcomes are generally promising, with 86% to 96% of surgically treated patients remaining asymptomatic for 5 to 10 years. Endovascular treatment provides effective symptom relief in approximately 85% of patients and is considered a safe and effective option for appropriately selected candidates. These considerations are vital for optimizing patient care after chronic mesenteric ischemia diagnosis.
Enhancing Healthcare Team Outcomes in Chronic Mesenteric Ischemia
Optimal management of CMI requires a collaborative, interprofessional healthcare team approach to enhance patient-centered care, ensure safety, and improve overall outcomes. The often nonspecific presentation of abdominal angina can make early chronic mesenteric ischemia diagnosis challenging. Effective coordination among radiologists, gastroenterologists, and emergency physicians is crucial for timely and accurate diagnosis. Once CMI is identified, vascular or general surgeons, supported by operative and intensive care unit nurses, become central to implementing advanced interventions such as endovascular stenting or open surgical revascularization. Effective communication within the team is essential to ensure accurate diagnosis and prompt treatment, thereby reducing morbidity and mortality associated with delays in care.
Primary care clinicians play a vital role in managing modifiable risk factors for CMI. They are instrumental in educating patients on smoking cessation, promoting heart-healthy diets, and managing weight, thereby addressing the key cardiac risk factors that contribute to a significant proportion of CMI-related deaths. Cardiologists are essential in assessing and managing underlying cardiac conditions, while pharmacists contribute by optimizing antiplatelet and lipid-lowering therapies to prevent complications such as graft thrombosis and to manage hyperlipidemia. Statin medications are particularly important in these patients to manage hypercholesterolemia and reduce atherosclerotic progression.
Post-treatment, ongoing monitoring by the interprofessional team is critical to detect any recurrence of symptoms or complications, such as graft occlusion leading to recurrent bowel ischemia. Regular follow-up appointments and clear, consistent communication among all team members ensure timely intervention when needed. This collaborative, team-based approach is essential for enhancing long-term outcomes and improving overall team performance in the comprehensive care of patients with chronic mesenteric ischemia diagnosis.
Review Questions
(Note: Review questions from the original article are omitted as per instructions)
References
(Note: References from the original article are included as per instructions)
1.Tayama S, Sakamoto T, Taguchi E, Sawamura T, Koyama J, Ogawa H, Nakao K. Successful stenting to superior mesenteric artery (SMA) after endovascular aneurysm repair (EVAR) of abdominal aorta. J Cardiol Cases. 2010 Oct;2(2):e78-e82. [PMC free article: PMC6265087] [PubMed: 30532806]
2.Mosselveld P, van Werkum MH, Menting TP, Pieters AMMJ, Müller METM, Bosch FH. A case of progressive abdominal angina. Neth J Med. 2018 Jul;76(5):255. [PubMed: 30019683]
3.Melas N, Haji Younes A, Lindberg R, Magnusson P. A case of extreme weight loss due to mesenteric ischemia and antiphospholipid syndrome. Clin Case Rep. 2018 Jun;6(6):1055-1059. [PMC free article: PMC5986042] [PubMed: 29881563]
4.Prakash VS, Marin M, Faries PL. Acute and Chronic Ischemic Disorders of the Small Bowel. Curr Gastroenterol Rep. 2019 May 07;21(6):27. [PubMed: 31065817]
5.Allain C, Besch G, Guelle N, Rinckenbach S, Salomon du Mont L. Prevalence and Impact of Malnutrition in Patients Surgically Treated for Chronic Mesenteric Ischemia. Ann Vasc Surg. 2019 Jul;58:24-31. [PubMed: 31009732]
6.Ben Abdallah I, Cerceau P, Pellenc Q, Huguet A, Corcos O, Castier Y. Laparoscopic Surgery in Chronic Mesenteric Ischemia: Release of the Superior Mesenteric Artery from the Median Arcuate Ligament Using the Transperitoneal Left Retrorenal Approach. Ann Vasc Surg. 2019 Aug;59:313.e5-313.e10. [PubMed: 31009713]
7.Robles-Martín ML, Reyes-Ortega JP, Rodríguez-Morata A. A Rare Case of Ischemia-Reperfusion Injury After Mesenteric Revascularization. Vasc Endovascular Surg. 2019 Jul;53(5):424-428. [PubMed: 30982410]
8.Franca E, Shaydakov ME, Kosove J. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 2, 2023. Mesenteric Artery Thrombosis. [PubMed: 30969585]
9.Ishii R, Sakai E, Nakajima K, Matsuhashi N, Ohata K. Non-occlusive mesenteric ischemia induced by a polyethylene glycol with ascorbate-based colonic bowel preparation. Clin J Gastroenterol. 2019 Oct;12(5):403-406. [PubMed: 30937697]
10.Talledo Ó, Torres L, Valenzuela H, Calle A, Mena MA, De La Peña Ó, Lizarzaburu D. [Persistent abdominal pain caused by superior mesenteric artery and celiac trunk dissection that does not respond to conservative treatment]. Rev Gastroenterol Peru. 2017 Jul-Sep;37(3):262-266. [PubMed: 29093592]
11.Barret M, Martineau C, Rahmi G, Pellerin O, Sapoval M, Alsac JM, Fabiani JN, Malamut G, Samaha E, Cellier C. Chronic Mesenteric Ischemia: A Rare Cause of Chronic Abdominal Pain. Am J Med. 2015 Dec;128(12):1363.e1-8. [PubMed: 26291907]
12.Mensink PB, Moons LM, Kuipers EJ. Chronic gastrointestinal ischaemia: shifting paradigms. Gut. 2011 May;60(5):722-37. [PubMed: 21115543]
13.Campbell EA, Silberman M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jun 26, 2023. Bowel Necrosis. [PubMed: 30485003]
14.Scali ST, Ayo D, Giles KA, Gray S, Kubilis P, Back M, Fatima J, Arnaoutakis D, Berceli SA, Beck AW, Upchurch GJ, Feezor RJ, Huber TS. Outcomes of antegrade and retrograde open mesenteric bypass for acute mesenteric ischemia. J Vasc Surg. 2019 Jan;69(1):129-140. [PubMed: 30580778]
15.Schauer SG, Thompson AJ, Bebarta VS. Superior mesenteric artery syndrome in a young military basic trainee. Mil Med. 2013 Mar;178(3):e398-9. [PubMed: 23707134]
16.Mohapatra A, Salem KM, Jaman E, Robinson D, Avgerinos ED, Makaroun MS, Eslami MH. Risk factors for perioperative mortality after revascularization for acute aortic occlusion. J Vasc Surg. 2018 Dec;68(6):1789-1795. [PMC free article: PMC6252122] [PubMed: 29945836]
17.Nuzzo A, Huguet A, Corcos O. [Modern treatment of mesenteric ischemia]. Presse Med. 2018 Jun;47(6):519-530. [PubMed: 29776790]
18.Kanasaki S, Furukawa A, Fumoto K, Hamanaka Y, Ota S, Hirose T, Inoue A, Shirakawa T, Hung Nguyen LD, Tulyeubai S. Acute Mesenteric Ischemia: Multidetector CT Findings and Endovascular Management. Radiographics. 2018 May-Jun;38(3):945-961. [PubMed: 29757725]
19.Mendes BC, Oderich GS, Tallarita T, Kanamori KS, Kalra M, DeMartino RR, Shuja F, Johnstone JK. Superior mesenteric artery stenting using embolic protection device for treatment of acute or chronic mesenteric ischemia. J Vasc Surg. 2018 Oct;68(4):1071-1078. [PubMed: 29685508]
20.Alahdab F, Arwani R, Pasha AK, Razouki ZA, Prokop LJ, Huber TS, Murad MH. A systematic review and meta-analysis of endovascular versus open surgical revascularization for chronic mesenteric ischemia. J Vasc Surg. 2018 May;67(5):1598-1605. [PubMed: 29571626]
21.Naganuma T, Fujino Y, Mitomo S, Basavarajaiah S, Nakamura S. One-year follow-up optical coherence tomography after endovascular treatment with a new-generation zotarolimus-eluting stent for chronic mesenteric ischemia. Hellenic J Cardiol. 2017 May-Jun;58(3):233-235. [PubMed: 28341491]
22.Sultan S, Hynes N, Elsafty N, Tawfick W. Eight years experience in the management of median arcuate ligament syndrome by decompression, celiac ganglion sympathectomy, and selective revascularization. Vasc Endovascular Surg. 2013 Nov;47(8):614-9. [PubMed: 23942948]
23.Sharkawi M, Alfadhel HE, Burns MD, Given M, Lee MJ. Mid-term follow-up of stenting in chronic mesenteric ischaemia: a review of six cases. Ir J Med Sci. 2014 Jun;183(2):181-5. [PubMed: 23860825]
Disclosures: Ronak Patel declares no relevant financial relationships with ineligible companies.
Disclosures: Abdul Waheed declares no relevant financial relationships with ineligible companies.
Disclosures: Ali Kimyaghalam declares no relevant financial relationships with ineligible companies.
Disclosures: Michael Costanza declares no relevant financial relationships with ineligible companies.
